Funding
Turn ideas into impact
Show Me
Due: January 7, 2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-167
Due: January 7, 2027
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 – Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-377
Due: January 7, 2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-256
Due: January 7, 2027
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-032
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-026
Due: January 7, 2027
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-098
Due: January 7, 2027
Cancer Research Education Grants Program – Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
US $150,000
Type
Grant
Source
Federal
Opp Number
PAR-23-278
Due: January 7, 2027
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-379
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
US $1,515,000
Type
Grant
Source
Federal
Opp Number
PAR-25-025
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?